Dr Philipp Lurz (University of Leipzig, Leipzig, DE) discusses findings from the TRILUMINATE trial.
The purpose of the study was to evaluate the safety and effectiveness of the Tricuspid Valve Repair System (TVRS) for treating symptomatic moderate or greater tricuspid regurgitation (TR).
1. What was the TRILUMINATE trial?
2. Can you tell us about the TriClip technology and what it aims to address?
3. What was the design of the study?
4. What were your findings?
5. What further research is needed?
Recorded remotely from Leipzig, 2020.
Interviewer: Mirjam Boros
Recording Editor: Natascha Wienand